(S (S (VP (VBG Analyzing) (NP (JJ large-scale) (, ,) (JJ multi-experiment) (NNS studies)))) (VP (VBZ requires) (S (NP (NNS scientists)) (VP (TO to) (VP (VP (VB test) (NP (DT each) (JJ experimental) (NN outcome)) (PP (IN for) (NP (JJ statistical) (NN significance)))) (CC and) (ADVP (RB then)) (VP (VB assess) (NP (DT the) (NNS results)) (PP (IN as) (NP (DT a) (NN whole)))))))) (. .))
(S (NP (PRP We)) (VP (JJ present) (NP (NP (NNP Black) (NNP Box) (NNP FDR)) (PRN (-LRB- -LRB-) (NP (NNP BB-FDR)) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (JJ empirical-Bayes) (NN method)) (PP (IN for) (S (VP (VBG analyzing) (NP (JJ multi-experiment) (NNS studies)) (SBAR (WHADVP (WRB when)) (S (NP (JJ many) (NNS covariates)) (VP (VBP are) (VP (VBN gathered) (PP (IN per) (NP (NN experiment))))))))))))) (. .))
(S (NP (NNP BB-FDR)) (VP (VBZ learns) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (JJ black) (NN box) (JJ predictive) (NNS models)))) (S (VP (TO to) (VP (VP (VB boost) (NP (NN power))) (CC and) (VP (VB control) (NP (NP (DT the) (JJ false) (NN discovery) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP FDR)) (-RRB- -RRB-)))) (PP (IN at) (NP (NP (CD two) (NNS stages)) (PP (IN of) (NP (NN study) (NN analysis))))))))) (. .))
(S (PP (IN In) (NP (NNP Stage) (CD 1))) (, ,) (NP (PRP it)) (VP (VBZ uses) (NP (DT a) (JJ deep) (JJ neural) (NN network)) (ADVP (RB prior) (TO to) (VP (VB report) (SBAR (WHNP (WDT which) (NNS experiments)) (S (VP (VBD yielded) (NP (JJ significant) (NNS outcomes)))))))) (. .))
(S (PP (IN In) (NP (NNP Stage) (CD 2))) (, ,) (NP (NP (DT a) (JJ separate) (JJ black) (NN box) (NN model)) (PP (IN of) (NP (DT each) (NN covariate)))) (VP (VBZ is) (VP (VBN used) (S (VP (TO to) (VP (VB select) (NP (NP (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (JJ significant) (JJ predictive) (NN power)) (PP (IN across) (NP (DT all) (NNS experiments)))))))))))) (. .))
(S (PP (IN In) (NP (NNS benchmarks))) (, ,) (NP (JJ BB-FDR)) (VP (NNS outperforms) (NP (VBG competing) (JJ state-of-the-art) (NNS methods)) (PP (IN in) (NP (NP (DT both) (NNS stages)) (PP (IN of) (NP (NN analysis)))))) (. .))
(S (NP (PRP We)) (VP (VBP apply) (NP (JJ BB-FDR)) (PP (TO to) (NP (NP (CD two) (JJ real) (NNS studies)) (PP (IN on) (NP (NN cancer) (NN drug) (NN efficacy)))))) (. .))
(S (PP (IN For) (NP (DT both) (NNS studies))) (, ,) (NP (NNP BB-FDR)) (VP (VP (VBZ increases) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NP (JJ significant) (NNS outcomes)) (VP (VBN discovered)))))) (CC and) (VP (NNS selects) (NP (NP (NNS variables)) (SBAR (WHNP (WDT that)) (S (VP (VBP reveal) (NP (NP (JJ key) (JJ genomic) (NNS drivers)) (PP (PP (IN of) (NP (NN drug) (NN sensitivity) (CC and) (NN resistance))) (PP (IN in) (NP (NN cancer))))))))))) (. .))
